Poseida Therapeutics Taps Ex-Halozyme Atty As GC

Law360 (July 16, 2020, 6:26 PM EDT) -- Cancer-focused biotechnology group Poseida Therapeutics Inc. has added a life sciences industry veteran — who was formerly at Halozyme Therapeutics Inc. — as its new general counsel.

Poseida, based in San Diego, said in a Thursday announcement that Harry Leonhardt will serve as both general counsel and chief compliance officer at the company, which went public July 10. 

Leonhardt told Law360 on Thursday he already knew a lot of people at Poseida, which was a big reason why he decided to join the team.

"It's a really exciting company with incredible technology, and having the added factor of having worked with a...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!